DIFFERENCE BETWEEN USA AND EU AUTHORISATION TIMELINES AND TIME TO REIMBURSEMENT IN THE EU5
Author(s)
Sun D1, Beckerman R2
1CBPartners, New York City, NY, USA, 2CBPartners, New York, NY, USA
Presentation Documents
OBJECTIVES: The purpose of this study was to estimate the time difference between the FDA and EMA approvals, as well as time to reimbursement in the UK, GER, FRA, ESP and ITA after EMA approval. METHODS:
Conference/Value in Health Info
2014-05, ISPOR 2014, Palais des Congres de Montreal
Value in Health, Vol. 17, No. 3 (May 2014)
Code
PHP45
Topic
Health Policy & Regulatory
Topic Subcategory
Health Disparities & Equity
Disease
Multiple Diseases